1 | priority is distinguished patient | | | | | | | 2 | 0.65% |
2 | is distinguished patient care | | | | | | | 2 | 0.65% |
3 | our priority is distinguished | | | | | | | 2 | 0.65% |
4 | with local and multinational | | | | | | | 1 | 0.33% |
5 | loading moleac moleac ناموجود | | | | | | | 1 | 0.33% |
6 | ناموجود loading moleac moleac | | | | | | | 1 | 0.33% |
7 | desitin ناموجود loading moleac | | | | | | | 1 | 0.33% |
8 | pharmaceutical operation background shafayab | | | | | | | 1 | 0.33% |
9 | operation background shafayab is | | | | | | | 1 | 0.33% |
10 | background shafayab is committed | | | | | | | 1 | 0.33% |
11 | shafayab is committed to | | | | | | | 1 | 0.33% |
12 | is committed to meet | | | | | | | 1 | 0.33% |
13 | committed to meet the | | | | | | | 1 | 0.33% |
14 | about us our group | | | | | | | 1 | 0.33% |
15 | home about us our | | | | | | | 1 | 0.33% |
16 | experienced team with local | | | | | | | 1 | 0.33% |
17 | desitin desitin ناموجود loading | | | | | | | 1 | 0.33% |
18 | requirements and expectations of | | | | | | | 1 | 0.33% |
19 | and expectations of our | | | | | | | 1 | 0.33% |
20 | expectations of our customers | | | | | | | 1 | 0.33% |
21 | of our customers and | | | | | | | 1 | 0.33% |
22 | our customers and partners | | | | | | | 1 | 0.33% |
23 | customers and partners in | | | | | | | 1 | 0.33% |
24 | and partners in a | | | | | | | 1 | 0.33% |
25 | biomarin biomarin ناموجود loading | | | | | | | 1 | 0.33% |
26 | dynamic and challenging business | | | | | | | 1 | 0.33% |
27 | and challenging business environment | | | | | | | 1 | 0.33% |
28 | team with local and | | | | | | | 1 | 0.33% |
29 | employs a dedicated experienced | | | | | | | 1 | 0.33% |
30 | dedicated experienced team with | | | | | | | 1 | 0.33% |
31 | momentum and attitude 175 | | | | | | | 1 | 0.33% |
32 | top pharma company in | | | | | | | 1 | 0.33% |
33 | pharma company in iran | | | | | | | 1 | 0.33% |
34 | company in iran keeping | | | | | | | 1 | 0.33% |
35 | ناموجود loading boehringer boehringer | | | | | | | 1 | 0.33% |
36 | loading ibsa ibsa ناموجود | | | | | | | 1 | 0.33% |
37 | ناموجود loading ibsa ibsa | | | | | | | 1 | 0.33% |
38 | positive and moving forward | | | | | | | 1 | 0.33% |
39 | and moving forward momentum | | | | | | | 1 | 0.33% |
40 | moving forward momentum and | | | | | | | 1 | 0.33% |